Pediatric Retina – Retinopathy of Prematurity (ROP)
What is Retinopathy of Prematurity (ROP)?
Retinopathy of Prematurity (ROP) is a medical term used for a conceivable sight-threatening eye disorder affecting generally premature infants/newborns/babies, which emerges due to irregular blood vessels developing in the retina, the light-sensitive tissue lining the rear of the eye, targeting the babies, if not addressed or managed promptly, as it causes retinal detachment and permanent vision loss or blindness. So, such eye conditions require comprehending the causes, threat/risk factors, signs/symptoms, and timely cure/treatment to save the babies from getting influenced by short-term or long-term effects.
The ROP eye disorder targets babies, when their normal development of blood vessels in the retina is disturbed/disrupted, but it doesn’t affect the intrinsically developed infants in the final weeks of pregnancy, while in premature infants, where the development does not complete naturally, the abnormal blood vessels develop in response to changes in oxygen levels and other stressors, making the baby susceptible to leaking of blood or bleeding and affecting him with scarring and retinal detachment.
Risk Factors
The risk of ROP increases with the degree of prematurity and low birth weight. Other contributing factors include:-
- Oxygen Therapy – High or fluctuating levels of oxygen given to premature infants can disrupt normal retinal development.
- Infections – Neonatal infections or sepsis can increase the risk of abnormal blood vessel growth.
- Anemia and Blood Transfusions – These conditions may contribute to the progression of ROP.
- Poor Weight Gain – Insufficient postnatal growth can exacerbate retinal vascular abnormalities.
Stages of ROP
ROP is classified into five stages based on its severity:-
- Stage 1 – Mild abnormal blood vessel growth. Often resolves without treatment.
- Stage 2 – Moderate abnormal growth with a demarcation line between vascular and non-vascular retina.
- Stage 3 – Severe abnormal growth with the formation of a ridge and abnormal vessels extending into the vitreous.
- Stage 4 – Partial retinal detachment.
- Stage 5 – Total retinal detachment, leading to blindness if untreated.
Symptoms
ROP typically does not present visible symptoms in the early stages. It is detected through a retinal examination performed by an ophthalmologist. In advanced stages, parents may notice signs such as:-
- White pupils (Leukocoria)
- Misaligned eyes (strabismus)
- Vision problems or blindness
Diagnosis
Screening for ROP is essential for all at-risk premature infants. A detailed eye examination, including indirect Ophthalmoscopy, is conducted between 4 to 6 weeks after birth. Regular follow-ups are scheduled based on the severity of the condition.
Treatment
The treatment for ROP depends on its stage and severity. Common approaches include:-
Laser Therapy (Photocoagulation)
- A widely used method to stop abnormal blood vessel growth by targeting the peripheral areas of the retina
Cryotherapy
- Freezing treatment applied to the peripheral retina to halt disease progression.
Anti-VEGF Injections
- Medications like Bevacizumab are injected into the eye to inhibit vascular endothelial growth factor (VEGF), reducing abnormal blood vessel growth.
Surgical Intervention
- In advanced cases with retinal detachment, procedures such as scleral buckling or vitrectomy are performed to restore retinal attachment.
Prevention and Prognosis
Preventing ROP involves carefully managing oxygen levels in premature infants, ensuring adequate nutrition, and minimizing complications like infections. Regular screening and prompt treatment significantly improve the prognosis, with many children achieving good visual outcomes. However, severe cases may result in lifelong vision impairment, emphasizing the importance of early intervention.
Conclusion
Retinopathy of Prematurity is a serious condition requiring vigilance in premature infants. Awareness, routine screening, and timely treatment are essential to prevent vision loss and support healthy retinal development. Collaboration between neonatologists, pediatric ophthalmologists, and caregivers plays a pivotal role in ensuring optimal outcomes for affected infants.
